Predicta Med Israeli Company

Predicta Med is a platform that enables early detection and intervention selection of autoimmune diseases. Its platform gives healthcare providers an AI-powered method for shortening the diagnostic process of identifying autoimmune diseases and by that could enhance provider’s efficiency, improve treatment effectiveness and patient's care. A process which typically takes more than four years and at least four different doctors can be shortened significantly using the platform.